Sensorion’s Phase 1/2 Audiogene trial of the gene therapy SENS-501 for infants and toddlers with OTOF-related congenital deafness shows promising early safety and hearing improvement data, particularly in one patient, with a higher dose cohort now underway.
A look at what we now know about how COVID-19 has been found to affect the auditory system, based on a review of the literature.
AI seems to be everywhere now, but are hearing care professionals ready to accept this new technology?
Inspired by the silent flight of owls, researchers have developed an aerogel that effectively absorbs both high- and low-frequency noise, offering a new solution to combat noise pollution in vehicles and industrial settings.
The VisualEyes VNG update features new, data-driven assessments to help clinicians understand how patients function in daily activities.
Citadel Texas' Citadel Digital Signage software suite now features a new Android app and media player designed to boost customer engagement.
